NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through ...
With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...
Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback